Discover how microfluidic technology is transforming multiple myeloma detection through liquid biopsy, replacing painful bone marrow procedures with simple blood tests.
Discover how SAR650984 (isatuximab) disrupts the CD38-CD31 adhesion axis in multiple myeloma, unmoors cancer cells from bone marrow, and triggers multiple lethal pathways.